XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $538,293 | -9.6% | 15,758 | +1.8% | 0.04% | -10.3% |
| Q2 2023 | $595,672 | -24.4% | 15,472 | -29.7% | 0.04% | -17.0% |
| Q1 2023 | $787,809 | +56.5% | 22,012 | +72.4% | 0.05% | +80.8% |
| Q4 2022 | $503,482 | +25074.1% | 12,769 | +1630.2% | 0.03% | – |
| Q2 2017 | $2,000 | -99.3% | 738 | -97.9% | 0.00% | -100.0% |
| Q4 2016 | $269,000 | +796.7% | 34,928 | +1243.4% | 0.03% | +725.0% |
| Q2 2015 | $30,000 | +76.5% | 2,600 | +160.0% | 0.00% | +100.0% |
| Q1 2015 | $17,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |